StockData

Broadridge Financial Solutions vs MSCI

BR and MSCI side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BR and MSCI compare

MSCI is the larger company, worth 2.1 times as much as Broadridge Financial Solutions ($47.1B against $21.9B).

On earnings, Broadridge Financial Solutions is cheaper: it trades at 20.0× trailing earnings, against 34.8× for MSCI.

MSCI grew revenue faster over the last twelve months (12.3% versus 8.5% for Broadridge Financial Solutions).

MSCI keeps more of each dollar of sales as profit, with a net margin of 40.3% compared with 15.0% at Broadridge Financial Solutions.

Both pay dividends: Broadridge Financial Solutions yields 2.1% and MSCI 1.2%.

Broadridge Financial Solutions scores higher on the StockData Score (22 against 18 for MSCI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBRMSCI
Size and price
Market cap$21.9B$47.1B
Share price$192.45$658.17
Change, 1 year−14.0%13.3%
Change, 5 years10.5%0.20%
Beta (5Y)0.811.16
Employees16K6,268
StockData Score
Total score22 (better)18
Valuation score4 (better)2
Growth score35 (better)
Performance score6 (better)4
Health score5 (better)3
Dividend score44
Valuation
P/E20.0× (better)34.8×
P/S2.9× (better)13.7×
P/B7.7×–
EV/EBITDA17.2× (better)27.6×
P/FCF17.2× (better)29.9×
PEG0.92 (better)2.57
FCF yield5.8% (better)3.3%
Fair value$233.30$594.74
Margin of safety17.5% (better)−10.7%
Growth
Revenue growth (TTM)8.5%12.3% (better)
Revenue growth, 5Y average8.4%13.1% (better)
Net income growth (TTM)33.9% (better)13.1%
EPS growth (TTM)35.2% (better)19.7%
EPS growth, 5Y average15.6%17.1% (better)
Profitability
Gross margin31.8%82.9% (better)
Operating margin17.4%55.7% (better)
Net margin15.0%40.3% (better)
FCF margin17.1%45.9% (better)
Return on equity40.9%–
Return on invested capital18.6%49.1% (better)
Financial health
Debt / equity1.15–
Net debt / EBITDA1.98 (better)3.33
Interest coverage11.6× (better)6.9×
Current ratio1.24 (better)0.82
Altman Z-score4.236.48 (better)
Piotroski F-score88
Dividends and buybacks
Dividend yield2.1% (better)1.2%
Payout ratio39.4%42.1%
Years of dividend growth17 (better)11
Dividend growth, 5Y average11.1%19.8% (better)
Buyback yield2.8%4.3% (better)
Shareholder yield4.8%5.5% (better)
Ownership
Held by institutions94.5%94.4%
Held by insiders0.44%3.6%
Insider net buying, 12 months−$2.7M$7.1M (better)
Superinvestors holding14 (better)
Short interest, % of float3.1%2.0%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.